Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gemcitabine (gemzar) (1 trial)
Lymphoma (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Trials (1 total)
Trial APIs (1 total)